Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) ROCURONIUM BROMIDE injection for intravenous use 50mg/5mL
Section 19A approved medicine
(Approval lapsed) ROCURONIUM BROMIDE injection for intravenous use 50mg/5mL
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
DBL ROCURONIUM BROMIDE INJECTION rocuronium bromide 50mg/5mL injection solution vial - ARTG 161275
Indication(s)
Rocuronium bromide Injection is indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.